- Investigator
- Yazan Radaideh
- Ages
- 18 Years - 79 Years
- Sexes
- All
Clinical trials
-
PICASSO: Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial -
RECOVER-ENERGIZE: A Platform Protocol for Evaluation of Interventions for Exercise Intolerance in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) - Investigators
- Carmen Isache, Jorge L Verdecia
- Ages
- 18 Years - 80 Years
- Sexes
- All
-
BHV7000-304: A Phase 2/3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000 - Investigators
- Ramon E Bautista, Suparna R Krishnaiengar, Katherine A Zarroli
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma - Investigator
- Kethandapatti Balaji
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
Switching from Clopidogrel to Low-dose Prasugrel in Patients at Dual-risk Following Percutaneous Coronary Intervention: TAILOR-BLEED-2 study - Investigators
- Dominick J Angiolillo, Luis G Ortega Paz
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
A Study of the Efficacy and Safety of Treatment With MNKD-101 When Added to GBT in Participants with Pulmonary Nontuberculous Mycobacterial Infection - Ages
- 18 Years - 85 Years
- Sexes
- All
-
Phase III, randomized, double-blind, placebo-controlled study to assess BI 1291583 2.5 mg once daily for up to 76 weeks in patients with bronchiectasis - Investigator
- Michael D Schweitzer Barrios
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Systemic Lupus Erythematosus (SLE) - Investigator
- Gurjit S Kaeley
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All